Celanese Corp

For the period ended May 5, 2026. Filed May 5, 2026.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

May 5, 2026 · Filed May 5, 2026

CE$46.49-2.8%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.2 · Table

Table 2

Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited

Q1 '26 · 2025 · Q4 '25 · Q3 '25 · Q2 '25 · Q1 '25
(In $ millions, except percentages)
Operating Profit (Loss) / Operating Margin
Engineered Materials	221	16.7%	(958)	(17.8)%	111	8.7%	(1,327)	(95.9)%	164	11.4%	94	7.3%
Acetyl Chain	95	9.2%	539	12.7%	90	9.6%	135	12.7%	153	13.7%	161	14.4%
Other Activities(1)	(102)		(367)		(108)		(83)		(86)		(90)
Total	214	9.2%	(786)	(8.2)%	93	4.2%	(1,275)	(52.7)%	231	9.1%	165	6.9%
Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials	2		6		—		3		1		2
Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain	2		8		3		1		2		2
Operating Profit (Loss) Attributable to Celanese Corporation	210	9.0%	(800)	(8.4)%	90	4.1%	(1,279)	(52.9)%	228	9.0%	161	6.7%
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation
Engineered Materials	219	16.5%	(964)	(17.9)%	111	8.7%	(1,330)	(96.1)%	163	11.3%	92	7.1%
Acetyl Chain	93	9.0%	531	12.5%	87	9.3%	134	12.6%	151	13.5%	159	14.2%
Other Activities(1)	(102)		(367)		(108)		(83)		(86)		(90)
Total	210	9.0%	(800)	(8.4)%	90	4.1%	(1,279)	(52.9)%	228	9.0%	161	6.7%
Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation
Engineered Materials	32		109		32		35		25		17
Acetyl Chain	2		132		42		44		43		3
Other Activities(1)	3		15		3		4		3		5
Total	37		256		77		83		71		25
Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation
Engineered Materials	—		3		3		—		—		—
Acetyl Chain	—		—		—		—		—		—
Other Activities(1)	5		52		47		2		1		2
Total	5		55		50		2		1		2
Certain Items Attributable to Celanese Corporation (Table 8)
Engineered Materials	(31)		1,572		37		1,495		25		15
Acetyl Chain	36		32		17		9		1		5
Other Activities(1)	18		35		(20)		16		16		23
Total	23		1,639		34		1,520		42		43
Adjusted EBIT / Adjusted EBIT Margin
Engineered Materials	220	16.6%	720	13.4%	183	14.3%	200	14.5%	213	14.8%	124	9.6%
Acetyl Chain	131	12.6%	695	16.4%	146	15.5%	187	17.6%	195	17.5%	167	15.0%
Other Activities(1)	(76)		(265)		(78)		(61)		(66)		(60)
Total	275	11.8%	1,150	12.0%	251	11.4%	326	13.5%	342	13.5%	231	9.7%

(1)Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 2

Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)

Q1 '26 · 2025 · Q4 '25 · Q3 '25 · Q2 '25 · Q1 '25
(In $ millions, except percentages)
Depreciation and Amortization Expense(1)
Engineered Materials	104		441		105		115		112		109
Acetyl Chain	63		252		64		63		64		61
Other Activities(2)	13		50		15		13		12		10
Total	180		743		184		191		188		180
Operating EBITDA / Operating EBITDA Margin
Engineered Materials	324	24.5%	1,161	21.5%	288	22.6%	315	22.8%	325	22.5%	233	18.1%
Acetyl Chain	194	18.7%	947	22.4%	210	22.3%	250	23.6%	259	23.2%	228	20.4%
Other Activities(2)	(63)		(215)		(63)		(48)		(54)		(50)
Total	455	19.5%	1,893	19.8%	435	19.7%	517	21.4%	530	20.9%	411	17.2%

(1)Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.

(2)Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

Table 3

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.